Bill Text: MO HB1874 | 2014 | Regular Session | Introduced

---

Bill Title: Allows patients with cancer who have been prescribed disease-managing medicines to receive a partial rebate of their private health insurance co-payments or coinsurance

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced - Dead) 2014-02-25 - Referred: Health Insurance(H) [HB1874 Detail]

Download: Missouri-2014-HB1874-Introduced.html

---

SECOND REGULAR SESSION

HOUSE BILL NO. 1874

97TH GENERAL ASSEMBLY

---

 

 

INTRODUCED BY REPRESENTATIVE MOLENDORP.

6042H.01I                                                                                                                                                  D. ADAM CRUMBLISS, Chief Clerk

---

 

AN ACT

To repeal section 376.823, RSMo, and to enact in lieu thereof one new section relating to health insurance rebates for patients with chronic illnesses.

---

Be it enacted by the General Assembly of the state of Missouri, as follows:

            Section A. Section 376.823, RSMo, is repealed and one new section enacted in lieu thereof, to be known as section 376.823, to read as follows:

            376.823. Section 191.905 shall not apply to programs established by pharmaceutical companies for the purposes of providing a partial rebate of private health insurance co-payments and coinsurance to patients with multiple sclerosis, cancer, or other chronic, potentially disabling, or life-threatening conditions who have been prescribed disease-managing medicines for which there are no generic equivalents.

•